Clinical trial
Study of the Protective Effect of an Injectable Influenza Vaccine Against…
NCT00216242 · ID Biomedical Corporation, Quebec, Industry · Unknown status
Key facts
| NCT number | NCT00216242 |
|---|---|
| Title | Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o. |
| Official title | A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Fluviral™ Influenza Vaccine in Healthy Adults 18 to 49 Years of Age |
| Lead sponsor | ID Biomedical Corporation, Quebec, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Influenza virus vaccine (Fluviral), Saline placebo |
| Enrollment | 7,400 |
| Start date | Sep 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 11, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: